Topical Antifungal Therapy for Vulvovaginal Candidiasis

Uncomplicated Vulvovaginal Candidiasis

Any topical azole (clotrimazole, miconazole, terconazole, butoconazole, or tioconazole) can be used because no single agent has demonstrated superiority; cure rates range from 80 % to 90 %【1】.
The Infectious Diseases Society of America (IDSA) guideline states that all topical azoles are equally effective for uncomplicated disease and does not favor one agent over another【2】【3】【4】.

Recommended dosing regimens (all cited from the same source):

Agent	Formulation	Dose & Route	Duration
Clotrimazole	1 % cream	5 g intravaginally	7–14 days
Clotrimazole	100 mg vaginal tablet	1 tablet daily	7 days
Miconazole	2 % cream	5 g intravaginally	7 days
Terconazole	0.4 % cream	5 g intravaginally	7 days
Terconazole	0.8 % cream	5 g intravaginally	3 days
Terconazole	80 mg suppository	1 suppository	3 days
Butoconazole	2 % cream	5 g intravaginally	3 days
Tioconazole	6.5 % ointment	5 g intravaginally	single application	【1】

In patients with severe symptoms, immunocompromise, diabetes, pregnancy, or recurrent infection, extend topical therapy to 5–7 days to achieve adequate response【2】【3】【4】.

Candida glabrata (often azole‑resistant):
- Boric acid 600 mg intravaginally daily for 14 days is effective when azoles fail【2】【3】【4】.
- Nystatin 100 000 U intravaginal suppositories daily for 14 days is an alternative【1】【2】.
- Compounded 17 % flucytosine cream, alone or combined with 3 % amphotericin B cream, can be used for recalcitrant cases【2】【3】【4】.
Candida krusei remains susceptible to all topical antifungal agents despite fluconazole resistance【2】【3】.

Initiate induction therapy with any topical azole for 10–14 days, followed by maintenance therapy.
Maintenance options (both supported by the same evidence):
- Clotrimazole cream 200 mg applied twice weekly【2】【3】.
- Clotrimazole vaginal suppository 500 mg once weekly【2】【3】.
Continue maintenance for at least 6 months; recurrence occurs in 40–50 % of patients after cessation【2】【3】【4】.

Confirm infection before treatment: perform a wet‑mount with 10 % potassium hydroxide to visualize yeast/hyphae and verify a normal vaginal pH (4.0–4.5)【4】【5】.
If microscopy is negative, obtain vaginal cultures to identify the Candida species【4】【5】.

Topical azoles and oral azoles achieve equivalent cure rates for uncomplicated disease; selection should be based on patient preference, cost, and contraindications【3】【4】【5】.
During pregnancy, only topical therapy is recommended; all topical azoles are considered safe, while oral agents should be avoided【1】.